Lower-Cost Hospitals Can Get Better Angioplasty Outcomes

Hospitals will face growing pressure to reduce costs and improve outcomes as transparency programs reveal comparative performance.
Published Online: October 28, 2013
The burning in his chest and aching in his arm told Charles, a resident of Kernersville, N.C., that he had to go to the hospital.

But which hospital? Rather than check published data comparing hospital quality and costs, the computer analyst did what many Americans do. He said he chose a hospital based on a recommendation from someone he knew—in this case, his daughter, who previously had received good care at Forsyth Medical Center in nearby Winston-Salem.

After he arrived at the emergency room, a cardiologist performed an emergency cardiac catheterization, known as a percutaneous coronary intervention, or PCI. He snaked a thin tube from Charles' groin through his blood vessels to his heart, broke up a blood clot, and left behind a metal stent to keep the artery open. Charles, who didn't want his last name used for this article, spent four days in the hospital and later returned for routine follow-up care.

Read the full story here: http://bit.ly/1aADHqm

Source: Modern Healthcare

Recommended Articles
The UK government has come up with an innovative plan to increase public awareness of the increasing price of prescription drugs and what it costs the healthcare system
In this seventh segment of the Healthcare Reform Stakeholders Summit, Spring 2015 series, Francois de Brantes, MS, MBA, and Arthur Vercillo, MD, FACS, discussed a number of issues related to pricing transparency, including access to information, decreased pricing variability, and antitrust concerns.
During this one-on-one interview, a part of the Oncology Stakeholders Summit, Spring 2015 series, Michael Kolodziej, MD, discusses payer considerations regarding coverage for new cancer treatments such as immuno-oncology therapies.
Providing the cost of care beforehand will allow the patient enough time to understand what he or she may be getting into, similar to signing a contract, according to Austin Frakt, PhD, health economist and researcher.
Earlier this month, the FDA took steps to prevent the online sale of counterfeit and illegal medicinal products, which can be a significant health risk to the population.